Nanobiotix
NBTX
9 hedge funds and large institutions have $39.1M invested in Nanobiotix in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
121% more capital invested
Capital invested by funds: $17.7M → $39.1M (+$21.4M)
80% more funds holding
Funds holding: 5 → 9 (+4)
2.51% more ownership
Funds ownership: 9.83% → 12.35% (+2.5%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JJ
Johnson & Johnson
New Brunswick,
New Jersey
|
+$7.96M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$4.45M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$92.9K |
| 4 |
Morgan Stanley
New York
|
+$14.1K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$5.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$4.19M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.63K |
| 3 |
JP Morgan Chase
New York
|
-$10 |
NBTX Hedge Fund Activity: Q3 2023 in Review
9 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q3 2023, worth a combined $39.1M — up 121% from $17.7M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NBTX positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Johnson & Johnson, opening a new position worth an estimated $7.96M. The largest seller was Perceptive Advisors, cutting an estimated $4.19M.
- 9 institutional investors held Nanobiotix (NBTX) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $39.1M of Nanobiotix stock for Q3 2023, up 121% quarter-over-quarter.
- 5 funds opened new Nanobiotix positions in Q3 2023 and 1 closed out, a net change of +4 holders.
- The largest Nanobiotix buyer in Q3 2023 was Johnson & Johnson, an estimated $7.96M added.
- The largest Nanobiotix seller in Q3 2023 was Perceptive Advisors, an estimated $4.19M sold.
Based on aggregated 13F filings for Q3 2023.